HuGE Literature Finder
Records 1 - 12
| Effects of methylenetetrahydrofolate reductase single-nucleotide polymorphisms on breast, cervical, ovarian, and endometrial cancer susceptibilities.
Chronic diseases and translational medicine 2021 Sep 7 (3): 169-181.
Wang Zheng, Li Kai, Ouyang Ling, Iko Hidasa, Safi Ahmad Javid, Gao Sh
| Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses.
Journal of ovarian research 2021 11 14 (1): 153.
Tanha Kiarash, Mottaghi Azadeh, Nojomi Marzieh, Moradi Marzieh, Rajabzadeh Rezvan, Lotfi Samaneh, Janani Lei
| Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.
Bioscience reports 2020 Jul .
Xiong Ying, Bian Ce, Lin Xiaojuan, Wang Xiaoli, Xu Kehui, Zhao X
| Association of MTHFR 677C>T Polymorphism with Susceptibility to Ovarian and Cervical Cancers: A Systematic Review and Meta-Analysis.
Asian Pacific journal of cancer prevention : APJCP 2019 09 20 (9): 2569-2577.
Karimi-Zarchi Mojgan, Moghimi Mansour, Abbasi Hajar, Hadadan Amaneh, Salimi Erfaneh, Morovati-Sharifabad Majid, Akbarian-Bafghi Mohammad Javad, Zare-Shehneh Masoud, Mosavi-Jarrahi Alireza, Neamatzadeh Hosse
| MTHFR C677T polymorphism and breast, ovarian cancer risk: a meta-analysis of 19,260 patients and 26,364 controls.
OncoTargets and therapy 2017 10 227-238.
He Lilin, Shen Yongxia
| ASSOCIATION OF MTHFR A1298C POLYMORPHISM WITH BREAST CANCER AND/OR OVARIAN CANCER RISK: AN UPDATED META-ANALYSIS.
African journal of traditional, complementary, and alternative medicines : AJTCAM 2016 13 (5): 72-86.
Liu Wei, Li Yi, Li Rui, Han Xiao, Ma Ying, Liu Bin, Kong Xiangzh
| MTHFR A1298C polymorphism and ovarian cancer risk: a meta-analysis.
Genetics and molecular research : GMR 2015 14 (3): 8211-8.
Shi X Y, Shen
| Association between MTHFR gene polymorphism and the risk of ovarian cancer: a meta-analysis of the literature.
Current pharmaceutical design 2014 20 (11): 1632-8.
Pu Danhua, Jiang Shi-Wen, Wu J
| Folate intake and MTHFR polymorphism C677T is not associated with ovarian cancer risk: evidence from the meta-analysis.
Molecular biology reports 2013 Dec 40 (12): 6547-60.
Li Chenglin, Chen Peizhan, Hu Pingting, Li Mian, Li Xiaoguang, Guo He, Li Jingquan, Chu Ruiai, Zhang Wei, Wang H
| The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.
Molecular biology reports 2013 Mar 40 (3): 2061-8.
Ma Chengbin, Liu Yan, Zhang Wenying, Liu Pi
| MTHFR polymorphisms and ovarian cancer risk: a meta-analysis.
Molecular biology reports 2012 Nov 39 (11): 9863-8.
Liu Lu, Liao Shao-Guang, Wang Ya-J
| MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (8): 3937-42.
Ding Xiao-Ping, Feng Li, Ma
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 20, 2023
- Content source: